Lei, P http://orcid.org/0000-0001-5652-1962
Ayton, S
Appukuttan, A T
Moon, S
Duce, J A
Volitakis, I
Cherny, R
Wood, S J
Greenough, M
Berger, G
Pantelis, C http://orcid.org/0000-0002-9565-0238
McGorry, P
Yung, A
Finkelstein, D I
Bush, A I
Article History
Received: 8 January 2016
Revised: 25 April 2016
Accepted: 9 May 2016
First Online: 12 July 2016
Competing interests
: Dr Finkelstein is a paid scientific consultant for Prana Biotechnology. Dr Bush is a shareholder in Prana Biotechnology, Eucalyptus, Mesoblast, Brighton Biotech and Nextvet, and a paid consultant for Collaborative Medicinal Developments. Dr Pantelis has participated on Advisory Boards for Janssen-Cilag, Astra-Zeneca, Lundbeck and Servier. He has received honoraria for talks presented at educational meetings organized by Astra-Zeneca, Janssen-Cilag, Eli Lilly, Pfizer, Lundbeck and Shire. Dr McGorry receives unrestricted research funding from Astra-Zenica, Eli Lilly, Janssen-Cilag, Pfizer and Novartis, as well as honoraria for educational activities with Astra-Zenica, Eli Lilly, Janssen-Cilag, Pfizer, Bristol Myer Squibb, Roche and the Lunbeck Institute. The remaining authors declare no conflicts of interest.